Please click here to obtain permission to reproduce this image.
Click on image to view larger version.
Figure 3 Plasma levels of endothelin-1 (ET-1), atrial natriuretic peptide (ANP), brain natriuretic peptide (BNP) and cyclic guanosine monophosphate (cGMP) before and after 14 weeks of treatment with candesartan cilexetil in 14 patients with mild to moderate congestive heart failure. *p < 0.05 vs. before.
|
